Executive summary Tuberculosis can be treated, prevented, and cured. Rapid, sustained
declines in tuberculosis deaths in many countries during the past 50 years provide …

Treatment of Tuberculosis | NEJM Skip to main content NEJM Group Follow Us Facebook
Twitter Instagram YouTube LinkedIn Prepare to become a physician, build your knowledge …

Background Tuberculosis is usually treated with a 6-month rifampin-based regimen.
Whether a strategy involving shorter initial treatment may lead to similar outcomes is …

Background Rifapentine-based regimens have potent antimycobacterial activity that may
allow for a shorter course in patients with drug-susceptible pulmonary tuberculosis. Methods …

Background Patients with highly drug-resistant forms of tuberculosis have limited treatment
options and historically have had poor outcomes. Methods In an open-label, single-group …

Abstract The American Thoracic Society, Centers for Disease Control and Prevention, and
Infectious Diseases Society of America jointly sponsored the development of this guideline …

In order to support countries in their effort to respond to the challenges posed by the TB
epidemic over the years, WHO has produced and regularly updated guidelines for the …

WHO operational handbook on tuberculosis Page 1 WHO operational handbook on
tuberculosis Module 4: Treatment Drug-susceptible tuberculosis treatment Page 2 WHO …

Tuberculosis kills more people than any other infectious disease. Three pivotal trials testing
4-month regimens failed to meet non-inferiority margins; however, approximately four-fifths …

Between 2011 and 2019, WHO has developed and issued evidence-based policy
recommendations on the treatment and care of patients with DR-TB. These policy …